血糖測定用ストリップの市場規模、シェア、成長分析、用途別、最終用途別、技術別、地域別- 産業別予測、2024～2031年

血糖測定用ストリップの世界市場規模は2022年に156億米ドルとなり、予測期間（2024～2031年）のCAGRは8.1%で、2023年の168億6,000万米ドルから2031年には314億5,000万米ドルに成長する見通しです。

世界の血糖測定用ストリップ市場は糖尿病管理に不可欠であり、国際糖尿病連合によると2045年までに7億人の成人が罹患すると予測される糖尿病有病率の上昇により一貫した成長を遂げています。この糖尿病患者の急増が、効果的なモニタリングに不可欠な血糖測定用ストリップの需要を牽引しています。さらに、リアルタイムの追跡を提供し、伝統的なフィンガースティック検査への依存を減らす、持続グルコースモニタリング（CGM）デバイスのような高度なグルコースモニタリングシステムへの顕著なシフトがあります。CGM技術の人気が高まっているにもかかわらず、血糖測定用ストリップは、その手頃な価格と使いやすさから、自己モニタリングのための好ましい選択肢であり続けており、従来の糖尿病管理ソリューションと高度な糖尿病管理ソリューションの両方にとって、引き続き強力な市場であることを示しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

血糖測定用ストリップの市場規模：用途別& CAGR（2024-2031）

• 市場概要
• 1型
• ２型
• 妊娠糖尿病
• 糖尿病前症

血糖測定用ストリップの市場規模：最終用途別& CAGR（2024-2031）

• 市場概要
• 個人
• 病院と診療所
• その他

血糖測定用ストリップの市場規模：技術別& CAGR（2024-2031）

• 市場概要
• グルコース脱水素酵素（GDH）
• グルコースオキシダーゼ
• その他

血糖測定用ストリップの市場規模：地域別& CAGR（2024-2031）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• Abbott Laboratories（USA）
• Roche Diagnostics（Switzerland）
• Siemens Healthineers（Germany）
• Thermo Fisher Scientific（USA）
• Danaher Corporation（USA）
• Eurofins Scientific（Luxembourg）
• Qiagen N.V.（Netherlands）
• Fujifilm Holdings Corporation（Japan）
• DiaSorin S.p.A.（Italy）
• Bio-Rad Laboratories, Inc.（USA）
• Sekisui Medical Corporation（Japan）
• Ortho Clinical Diagnostics（USA）
• Beckman Coulter, Inc.（USA）
• Myriad Genetics, Inc.（USA）
• Alere Inc.（USA）
• Quest Diagnostics Incorporated（USA）
• LabCorp（USA）
• BioMerieux SA（France）
• ARUP Laboratories（USA）
• MSD（Merck & Co., Inc.）（USA）

結論と推奨事項

Global Blood Glucose Test Strips Market size was valued at USD 15.6 billion in 2022 and is poised to grow from USD 16.86 billion in 2023 to USD 31.45 billion by 2031, growing at a CAGR of 8.1% during the forecast period (2024-2031).

The global blood glucose test strips market is essential to diabetes management, experiencing consistent growth due to the rising prevalence of diabetes, projected to affect 700 million adults by 2045, according to the International Diabetes Federation. This surge in diabetes cases drives demand for blood glucose test strips, vital for effective monitoring. Additionally, there's a notable shift toward advanced glucose monitoring systems like continuous glucose monitoring (CGM) devices, which offer real-time tracking and reduce the reliance on traditional fingerstick testing. Despite the increasing popularity of CGM technologies, blood glucose test strips remain the preferred choice for self-monitoring due to their affordability and ease of use, indicating a continued strong market for both traditional and advanced diabetes management solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Blood Glucose Test Strips market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Blood Glucose Test Strips Market Segmental Analysis

Global Blood Glucose Test Strips Market is segmented by Application, End Use, Technology and Region. Based on Application, the market is segmented into diabetes. Based on End Use, the market is segmented into individuals, hospitals and clinics and others. Based on Technology, the market is segmented into glucose dehydrogenase (GDH), glucose oxidase and others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Blood Glucose Test Strips Market

The blood glucose test strips market is experiencing significant growth, driven by heightened awareness of the importance of diabetes management and increased healthcare spending. As both governments and healthcare organizations globally prioritize early detection and effective treatment of diabetes, there is a corresponding rise in the adoption of glucose monitoring devices. This focus on improving patient outcomes has led to a surge in demand for blood glucose test strips, as individuals and healthcare providers alike recognize their essential role in managing diabetes effectively. Overall, this combination of awareness and investment in healthcare is propelling the market forward.

Restraints in the Global Blood Glucose Test Strips Market

The Global Blood Glucose Test Strips market faces significant challenges due to the rise of alternative monitoring methods, particularly continuous glucose monitoring (CGM) systems. These advanced technologies provide users with real-time glucose readings, minimizing the need for frequent fingerstick tests and enhancing convenience in monitoring blood sugar levels. As more patients and healthcare providers recognize the benefits of CGM systems, the demand for traditional blood glucose test strips may decline. Consequently, this shift towards more sophisticated and comprehensive glucose monitoring solutions could severely impact the market's growth and profitability, posing a notable restraint for blood glucose test strips manufacturers.

Market Trends of the Global Blood Glucose Test Strips Market

The global blood glucose test strips market is experiencing a notable shift towards continuous glucose monitoring (CGM) systems, driven by increasing consumer demand for efficient and convenient glucose management solutions. With advancements in sensor technology, CGMs allow for real-time tracking of blood glucose levels, significantly reducing the reliance on traditional fingerstick tests. This trend is further fueled by rising awareness among diabetes patients regarding the benefits of continuous monitoring, such as enhanced accuracy and the ability to make timely health decisions. As a result, manufacturers are innovating to integrate CGM capabilities, positioning themselves to cater to the evolving preferences of health-conscious consumers.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Blood Glucose Test Strips Market Size by Application & CAGR (2024-2031)

• Market Overview
• Type 1
• Type 2
• Gestational Diabetes
• Pre-Diabetes

Global Blood Glucose Test Strips Market Size by End Use & CAGR (2024-2031)

• Market Overview
• Individuals
• Hospitals and Clinics
• Others

Global Blood Glucose Test Strips Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Glucose Dehydrogenase (GDH)
• Glucose Oxidase
• Others

Global Blood Glucose Test Strips Market Size & CAGR (2024-2031)

• North America (Application, End Use, Technology)
  • USA
  • Canada
• Europe (Application, End Use, Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application, End Use, Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application, End Use, Technology)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application, End Use, Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Medical Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alere Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quest Diagnostics Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LabCorp (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARUP Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD (Merck & Co., Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations